Physician profile
Patrick David Scheurer
NPI 1306431713
$1,118.57
in general payments reported to CMS, 2019-2025
14 companies · $300 in 2025
The $300 reported for 2025 was more than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $311 · 2022: $291 · 2023: $177 · 2024: $38.93 · 2025: $300.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $516.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $516.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $324.08 | 2021-2022 | |
| Kci USA, INC. | $184.98 | 2021 | |
| Teleflex LLC | $159.00 | 2023-2025 | Quikclot, Manta |
| Abiomed | $123.97 | 2025 | |
| Tactile Systems Technology INC | $57.59 | 2022-2023 | Entre Plus, Flexitouch Plus |
| Smith+Nephew, INC. | $42.15 | 2024-2025 | Collagenase Santyl |
| Lemaitre Vascular, INC. | $39.20 | 2022-2025 | Artegraft Vascular Graft |
| Solventum Corporation | $37.41 | 2024-2025 | Prevena, V.A.C.Instill, V.A.C. Veraflo Cleanse Choice |
| Shockwave Medical, INC | $36.29 | 2025 | |
| Integra Lifesciences Corporation | $30.84 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Csl Behring | $26.96 | 2022 | |
| Pfizer INC. | $26.23 | 2021-2022 | |
| Arjo INC. | $16.01 | 2025 | |
| Medline Industries Lp | $13.86 | 2023 | Medline Industries, INC., Z-Guard |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Scheurer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.